U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Vitreoretinopathy

MedGen UID:
87480
Concept ID:
C0344290
Disease or Syndrome
Synonym: Vitreoretinal degeneration
SNOMED CT: Vitreoretinal degeneration (247182006)
 
HPO: HP:0007773
Monarch Initiative: MONDO:0020248

Definition

Ocular abnormality characterized by premature degeneration of the vitreous and the retina that may be associated with increased risk of retinal detachment. [from HPO]

Conditions with this feature

Proliferative vitreoretinopathy
MedGen UID:
66167
Concept ID:
C0242852
Disease or Syndrome
Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.
Marshall syndrome
MedGen UID:
82694
Concept ID:
C0265235
Disease or Syndrome
Marshall syndrome (MRSHS) is characterized by midfacial hypoplasia, cleft palate, ocular anomalies including high myopia and cataracts, sensorineural hearing loss, short stature with spondyloepiphyseal dysplasia, and arthropathy. In contrast to Stickler syndrome type II, it has less severe eye findings but striking ocular hypertelorism, more pronounced maxillary hypoplasia, and ectodermal abnormalities (summary by Shanske et al., 1997 and Ala-Kokko and Shanske, 2009).
Osteoporosis with pseudoglioma
MedGen UID:
98480
Concept ID:
C0432252
Disease or Syndrome
Osteoporosis-pseudoglioma syndrome (OPPG) is an autosomal recessive disorder characterized by severe osteoporosis and visual disturbance from childhood. Juvenile onset of osteoporosis manifests as long-bone fractures, vertebral compression fractures, kyphoscoliosis, deformity of extremities, and short stature. Congenital or early-onset visual disturbances arise from ophthalmologic problems including retinal detachment and microphthalmia (summary by Narumi et al., 2010).
Wagner syndrome
MedGen UID:
326741
Concept ID:
C1840452
Disease or Syndrome
Wagner vitreoretinopathy (WGVRP) is a rare vitreoretinal degeneration inherited as an autosomal dominant trait, first described in a large Swiss pedigree (Wagner, 1938) and subsequently identified in other families. Penetrance in Wagner syndrome is complete, and the disease manifests in childhood or adolescence with a progressive course. Affected individuals usually present with an 'empty' vitreous cavity with fibrillary condensation or avascular strands and veils. Additional features, which are variable and age-dependent, include chorioretinal atrophy with loss of the retinal pigment epithelium (RPE), lattice degeneration of the retina, complicated cataracts, mild myopia, and peripheral traction retinal detachment. Rod and cone electroretinography shows reduced b-wave amplitude and correlates with severe chorioretinal pathology. It is believed that liquefaction of vitreous initiates a degenerative cascade that results in the complex eye phenotype of Wagner syndrome (summary by Kloeckener-Gruissem et al., 2006). Patients with additional ocular features such as progressive nyctalopia (night blindness), visual field constriction, and chorioretinal atrophy, with loss of RPE and choriocapillaries on fluorescein angiography and rod-cone abnormalities on electroretinography, were initially believed to have a distinct clinical entity, which was designated 'erosive vitreoretinopathy' (ERVR). Extraocular abnormalities are not present in patients diagnosed with Wagner or erosive vitreoretinopathy (summary by Mukhopadhyay et al., 2006).
Enhanced S-cone syndrome
MedGen UID:
341446
Concept ID:
C1849394
Disease or Syndrome
Hereditary human retinal degenerative diseases usually affect the mature photoreceptor topography by reducing the number of cells through apoptosis, resulting in loss of visual function. Only one inherited retinal disease, the enhanced S-cone syndrome (ESCS), manifests a gain in function of photoreceptors. ESCS is an autosomal recessive retinopathy in which patients have increased sensitivity to blue light; perception of blue light is mediated by what is normally the least populous cone photoreceptor subtype, the S (short wavelength, blue) cones. People with ESCS also suffer visual loss, with night blindness occurring from early in life, varying degrees of L (long, red)- and M (middle, green)-cone vision, and retinal degeneration. The pattern of retinal dysfunction is a constant among ESCS patients, but the degree of clinically evident retinal degeneration can vary from minimal to severe. The latter condition is known as Goldmann-Favre syndrome. The altered ratio of S- to L/M-cone photoreceptor sensitivity in ESCS may be due to abnormal cone cell fate determination during retinal development (summary by Haider et al., 2000). Goldmann-Favre syndrome is characterized by a liquefied vitreous body with preretinal band-shaped structures (veil), macular changes in the form of retinoschisis or edema and pigmentary degeneration of the retina with hemeralopia and extinguished electroretinogram. Cataract is a complication. The disorder is to be distinguished from X-linked retinoschisis (312700) and from autosomal dominant hyaloideoretinal degeneration (143200).
Pigmented paravenous retinochoroidal atrophy
MedGen UID:
401413
Concept ID:
C1868310
Disease or Syndrome
Pigmented paravenous chorioretinal atrophy is a stationary disease of the ocular fundus in which bone corpuscle pigmentation is seen in a paravenous distribution. Patients are usually asymptomatic; diagnosis is based on the characteristic fundus appearance. Most cases have been reported in males (summary by Traboulsi and Maumenee, 1986).
Stickler syndrome type 1
MedGen UID:
810955
Concept ID:
C2020284
Disease or Syndrome
Stickler syndrome is a connective tissue disorder that can include ocular findings of myopia, cataract, and retinal detachment; hearing loss that is both conductive and sensorineural; midfacial underdevelopment and cleft palate (either alone or as part of the Pierre Robin sequence); and early-onset degenerative joint disease. Variable phenotypic expression of Stickler syndrome occurs both within and among families; interfamilial variability is in part explained by locus and allelic heterogeneity.
Spondyloepiphyseal dysplasia congenita
MedGen UID:
412530
Concept ID:
C2745959
Congenital Abnormality
Spondyloepiphyseal dysplasia congenita (SEDC) is an autosomal dominant chondrodysplasia characterized by disproportionate short stature (short trunk), abnormal epiphyses, and flattened vertebral bodies. Skeletal features are manifested at birth and evolve with time. Other features include myopia and/or retinal degeneration with retinal detachment and cleft palate (summary by Anderson et al., 1990).
Stickler syndrome, type 5
MedGen UID:
481972
Concept ID:
C3280342
Disease or Syndrome
Stickler syndrome is a connective tissue disorder that can include ocular findings of myopia, cataract, and retinal detachment; hearing loss that is both conductive and sensorineural; midfacial underdevelopment and cleft palate (either alone or as part of the Pierre Robin sequence); and early-onset degenerative joint disease. Variable phenotypic expression of Stickler syndrome occurs both within and among families; interfamilial variability is in part explained by locus and allelic heterogeneity.
Knobloch syndrome 1
MedGen UID:
1642123
Concept ID:
C4551775
Disease or Syndrome
Knobloch syndrome-1 (KNO1) is an autosomal recessive developmental disorder primarily characterized by typical eye abnormalities, including high myopia, cataracts, dislocated lens, vitreoretinal degeneration, and retinal detachment, with occipital skull defects, which can range from occipital encephalocele to occult cutis aplasia (summary by Aldahmesh et al., 2011). Genetic Heterogeneity of Knobloch Syndrome KNO2 (618458) is caused by mutation in the PAK2 gene (605022) on chromosome 3q29.
Knobloch syndrome 2
MedGen UID:
1812153
Concept ID:
C5676897
Disease or Syndrome
Knobloch syndrome-2 (KNO2) is characterized by severe vitreoretinal degeneration associated with occipital skull defects, ranging from mild encephalocele to abnormally pigmented hair. Developmental delay may be mild or severe (Antonarakis et al., 2022). For a general phenotypic description and discussion of genetic heterogeneity of Knobloch syndrome, see KNO1 (267750).

Professional guidelines

PubMed

Shaikh N, Srishti R, Khanum A, Thirumalesh MB, Dave V, Arora A, Bansal R, Surve A, Azad S, Kumar V
Indian J Ophthalmol 2023 Jan;71(1):28-38. doi: 10.4103/ijo.IJO_928_22. PMID: 36588205Free PMC Article
Dumbrăveanu L, Cușnir V, Bobescu D
Rom J Ophthalmol 2021 Oct-Dec;65(4):315-329. doi: 10.22336/rjo.2021.66. PMID: 35087972Free PMC Article
Liu Y, Wu N
Int J Nanomedicine 2021;16:1391-1403. Epub 2021 Feb 24 doi: 10.2147/IJN.S294807. PMID: 33658779Free PMC Article

Recent clinical studies

Etiology

Bai A, Sharma A, Chiang MY
J Glaucoma 2023 Jun 1;32(6):e66-e68. Epub 2023 Mar 30 doi: 10.1097/IJG.0000000000002222. PMID: 37054434
Wu F, Eliott D
Semin Ophthalmol 2021 May 19;36(4):218-223. Epub 2021 Feb 22 doi: 10.1080/08820538.2021.1890791. PMID: 33616467
Idrees S, Sridhar J, Kuriyan AE
Int Ophthalmol Clin 2019 Winter;59(1):221-240. doi: 10.1097/IIO.0000000000000258. PMID: 30585928Free PMC Article
Gilmour DF
Eye (Lond) 2015 Jan;29(1):1-14. Epub 2014 Oct 17 doi: 10.1038/eye.2014.70. PMID: 25323851Free PMC Article
Fong DS, Aiello LP, Ferris FL 3rd, Klein R
Diabetes Care 2004 Oct;27(10):2540-53. doi: 10.2337/diacare.27.10.2540. PMID: 15451934

Diagnosis

Özdek Ş, Özdemir Zeydanlı E, Baumal C, Hoyek S, Patel N, Berrocal A, Lopez-Cañizares A, Al-Khersan H, Kusaka S, Mano F, Jalali S, Lepore D, Akar S
Turk J Ophthalmol 2023 Feb 24;53(1):44-57. doi: 10.4274/tjo.galenos.2022.76436. PMID: 36847634Free PMC Article
Shaikh N, Srishti R, Khanum A, Thirumalesh MB, Dave V, Arora A, Bansal R, Surve A, Azad S, Kumar V
Indian J Ophthalmol 2023 Jan;71(1):28-38. doi: 10.4103/ijo.IJO_928_22. PMID: 36588205Free PMC Article
Claes C, Lafetá AP
Dev Ophthalmol 2014;54:188-95. Epub 2014 Aug 26 doi: 10.1159/000360466. PMID: 25196769
B S G, Pai GS, Pai AH, Vinekar AS, Pai HS, Noronha T, Fernandes MS
Kathmandu Univ Med J (KUMJ) 2013 Jan-Mar;11(41):91-3. doi: 10.3126/kumj.v11i1.11052. PMID: 23774424
Fong DS, Aiello LP, Ferris FL 3rd, Klein R
Diabetes Care 2004 Oct;27(10):2540-53. doi: 10.2337/diacare.27.10.2540. PMID: 15451934

Therapy

Wang WX, Xing M, Apte RS
JAMA Ophthalmol 2024 Jul 1;142(7):669-670. doi: 10.1001/jamaophthalmol.2024.1093. PMID: 38780937
Shaikh N, Srishti R, Khanum A, Thirumalesh MB, Dave V, Arora A, Bansal R, Surve A, Azad S, Kumar V
Indian J Ophthalmol 2023 Jan;71(1):28-38. doi: 10.4103/ijo.IJO_928_22. PMID: 36588205Free PMC Article
Idrees S, Sridhar J, Kuriyan AE
Int Ophthalmol Clin 2019 Winter;59(1):221-240. doi: 10.1097/IIO.0000000000000258. PMID: 30585928Free PMC Article
Papakostas TD, Vavvas D
Semin Ophthalmol 2018;33(1):70-74. Epub 2017 Nov 29 doi: 10.1080/08820538.2017.1353816. PMID: 29185844
Peyman GA, Schulman J
Surv Ophthalmol 1985 May-Jun;29(6):434-42. doi: 10.1016/0039-6257(85)90208-5. PMID: 3892742

Prognosis

Yao J, Hu LL, Li XM, Shan K, Zhou RM, Ge HM, Yao MD, Jiang Q, Zhao C, Yan B
Biomed Pharmacother 2019 Mar;111:548-554. Epub 2018 Dec 28 doi: 10.1016/j.biopha.2018.12.044. PMID: 30597308
Fraser S, Steel D
BMJ Clin Evid 2010 Nov 24;2010 PMID: 21406128Free PMC Article
Kroll P, Rodrigues EB, Hoerle S
Ophthalmologica 2007;221(2):78-94. doi: 10.1159/000098253. PMID: 17380062
Sasoh M, Smiddy WE
Retina 1995;15(5):388-93. doi: 10.1097/00006982-199515050-00003. PMID: 8594630
Hakin KN, Lavin MJ, Leaver PK
Graefes Arch Clin Exp Ophthalmol 1993 Jun;231(6):344-6. doi: 10.1007/BF00919031. PMID: 8339950

Clinical prediction guides

Liu D, Yan B, Yin Y, Chen F, Guo C, Li Q, Liu J, Pu L, Wu W, Luo J
Lab Invest 2024 Apr;104(4):102026. Epub 2024 Feb 1 doi: 10.1016/j.labinv.2024.102026. PMID: 38307209
Shaikh N, Srishti R, Khanum A, Thirumalesh MB, Dave V, Arora A, Bansal R, Surve A, Azad S, Kumar V
Indian J Ophthalmol 2023 Jan;71(1):28-38. doi: 10.4103/ijo.IJO_928_22. PMID: 36588205Free PMC Article
Pilli S, Murjaneh S
Retin Cases Brief Rep 2023 Jul 1;17(4):365-369. doi: 10.1097/ICB.0000000000001188. PMID: 34510049
Rizzo S, de Angelis L, Barca F, Bacherini D, Vannozzi L, Giansanti F, Faraldi F, Caporossi T
Eur J Ophthalmol 2022 Sep;32(5):2833-2839. Epub 2021 Nov 15 doi: 10.1177/11206721211057672. PMID: 34779683
Selvan H, Swamy DR, Temkar S, Venkatesh P, Gupta S
J Glaucoma 2018 Jan;27(1):e1-e6. doi: 10.1097/IJG.0000000000000810. PMID: 29088053

Recent systematic reviews

Tsui JC, Brucker AJ, Kim BJ, Kolomeyer AM
Retina 2023 Aug 1;43(8):1226-1239. doi: 10.1097/IAE.0000000000003770. PMID: 36893435
Abikoye TM, Idowu OO, Oluleye TS
Int J Clin Pract 2021 Dec;75(12):e14911. Epub 2021 Sep 26 doi: 10.1111/ijcp.14911. PMID: 34551184
Steel D
BMJ Clin Evid 2014 Mar 3;2014 PMID: 24807890Free PMC Article
Fraser S, Steel D
BMJ Clin Evid 2010 Nov 24;2010 PMID: 21406128Free PMC Article
Steel D, Fraser S
BMJ Clin Evid 2008 Feb 15;2008 PMID: 19450333Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...